Author name: admin1

I was concerned this would happen. The FDA did not think that the benefits in decreasing visceral fat in HIV positive people outweigh the risks of diabetes, joint pains and hyperglycemia. However, I know this drug works very effectively to decrease belly fat. The problem is that the fat returns when you get off the […]

TITAN & DUET Studies COMMENTARY No patient left behind-better treatments for resistant HIV infection The Lancet July 7, 2007 Bernard Hirschel a and Thomas Perneger ba. Division of Infectious Diseases, Geneva University Hospital, Geneva 1211, Switzerlandb. Clinical Epidemiology Service, Geneva University Hospital, Geneva, Switzerland Darunavir (TMC114) is a protease inhibitor specifically designed for “resistance to

I was part of this meeting and was very happy with the outcome. I hope the FDA and pharma listen to us. Representatives from the FDA, industry (Merck, Pfizer, Tibotec, Panacos and BI) , physician groups, Kaiser Permanente, researchers, and others were part of the discussion. **************************************HIV Research Group Calls for Improving System of Patient

Rates of anal cancer among gay and bisexual men are 35 times greater than the general population HIV+ men and women are 80 times more likely to have anal cancer. THE GOOD NEWS IS THAT ANAL CANCER IS POTENTIALLY PREVENTABLE AND HIGHLY CURABLE. Come to hear Houston’s Dr. Eric Haas speak about ways to detect

THIS GREAT INFORMATION WAS PROVIDED BY CLINICAL CARE OPTIONS. THESE ARE COMMENTS ABOUT CLINICAL STUDY DESIGN ISSUES THAT I FOLLOW VERY CLOSELY AS AN ACTIVIST. IT IS VERY INTERESTING TO ME HOW SOME COMPANIES CHOSE TO SHOW THEIR DATA AND HURRY THEIR STUDY ENROLLMENT AT THE EXPENSE OF PATIENT VOLUNTEERS. THE NEXT HIV DRUG TO

I have to thank TheBody.com for the opportunity to tell my story https://thebody.com/multidrug/stories_nelson.html

I have received emails in the past about people asking why they feel anxious or moody on Ziagen. This problem has happened to me and others and it is rarely discussed in the literature or in physician-patient conversations. *********************** In response to the persons who said they cannot sleep and feel anxious on Epzicom (Ziagen+Epivir

TOPIC: SURVIVING HIV RESISTANCE- How to avoid mistakes in using new HIV drugsReserve any lecture by calling 1-800- 810-3703 or email [email protected] TUESDAY, JUNE 12: MIAMI11 am- NoonJackson Health System1622 NW 12 Ave ACC West Room 125 WEDNESDAY, JUNE 13- PORT SAINT LUCIE10:30 am- noon5150 NW Milner Dr (off Midway Road)WEDNESDAY, JUNE 13- FORT LAUDERDALE6:30

On March 20, Watson Laboratories stopped the production of nandrolone decanoate (old brand name: Deca Durabolin), a low cost injectable anabolic used for HIV wasting, citing lack of raw material suppliers for the product. Patients found out when they went to their pharmacies for a prescription a week later. Although there are other generic makers

This was first brough to light by Michael Mooney in 1999. It took years but Serono is now paying for this troublesome corporate decision. You can read the original article in 1999 here: https://medibolics.com/kickback2.htm Ex-Serono executives acquitted in USA of bribing doctors 04/05/2007www.pharmatimes.com A federal grand jury has acquitted four former executives of Switzerland’s Serono,

Copyright © 2006 Bay Area Reporter, a division of Benro Enterprises, Inc. AIDS activists upset by dropped wasting drugby Heather [email protected] AIDS activists are mobilizing after Watson Pharmaceuticals last month dropped a common off-label drug used to assist patients with combating wasting and picked up a generic brand of an approved AIDS-related wasting medication that

Surviving HIV Resistance in the new era of HAART Date: 04/25/2007 Time: 12-2 p.m. Place: Doubletree Hotel Address: 700 King St. City: Wilmington State: Delaware Zip: 19801 Contact Person: Lori Campbell Organization/Company: AIDS Delaware Contact Email: [email protected] Contact Phone: 302-652-6776 Contact Fax: Event Description: A lecture for patients and clinicians. Topics include how to avoid